Literature DB >> 18495778

Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages.

Mikako Fujita1, Masami Otsuka, Masami Miyoshi, Boonruang Khamsri, Masako Nomaguchi, Akio Adachi.   

Abstract

The abilities of wild-type and vpx-defective human immunodeficiency virus type 2 (HIV-2) clones to synthesize viral DNA in human monocyte-derived macrophages (MDMs) and lymphocytic cells were comparatively and quantitatively evaluated. While the vpx-defective mutant directed the synthesis of viral DNA comparably to the wild-type virus and normally in lymphocytic cells, no appreciable viral DNA was detected in MDMs infected with the mutant. To substantiate this finding and to determine whether there is some specific region(s) in Vpx crucial for viral DNA synthesis in MDMs, we generated a series of site-specific point mutants of vpx and examined their phenotypes. The resultant five mutants, with no infectivity for MDMs, showed, without exception, the same defect as the vpx-defective mutant. Our results here clearly demonstrated that the entire Vpx protein is critical for reverse transcription of the HIV-2 genome in human MDMs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495778      PMCID: PMC2493314          DOI: 10.1128/JVI.01003-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC.

Authors:  J C Kappes; C D Morrow; S W Lee; B A Jameson; S B Kent; L E Hood; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage.

Authors:  X F Yu; Q C Yu; M Essex; T H Lee
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.

Authors:  Erwann Le Rouzic; Nadia Belaïdouni; Emilie Estrabaud; Marina Morel; Jean-Christophe Rain; Catherine Transy; Florence Margottin-Goguet
Journal:  Cell Cycle       Date:  2007-01-17       Impact factor: 4.534

5.  Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells.

Authors:  Fumiko Ueno; Hiroshi Shiota; Maki Miyaura; Akiko Yoshida; Akiko Sakurai; Junko Tatsuki; A Hajime Koyama; Hirofumi Akari; Akio Adachi; Mikako Fujita
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

6.  A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

Authors:  J K Yee; A Miyanohara; P LaPorte; K Bouic; J C Burns; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression.

Authors:  J S Lebkowski; S Clancy; M P Calos
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

9.  Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.

Authors:  Mikako Fujita; Akiko Sakurai; Akiko Yoshida; Maki Miyaura; A Hajime Koyama; Koji Sakai; Akio Adachi
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

Authors:  L E Henderson; R C Sowder; T D Copeland; R E Benveniste; S Oroszlan
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

View more
  45 in total

1.  Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.

Authors:  Wei Wei; Haoran Guo; Qimeng Gao; Richard Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 2.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

3.  Revising the Role of Myeloid cells in HIV Pathogenesis.

Authors:  Anupriya Aggarwal; Samantha McAllery; Stuart G Turville
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

4.  HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.

Authors:  Anna McCulley; Lee Ratner
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

5.  Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.

Authors:  J-M Humbert; C Frecha; F Amirache Bouafia; T H N'Guyen; S Boni; F-L Cosset; E Verhoeyen; F Halary
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.

Authors:  Caroline Goujon; Vanessa Arfi; Thomas Pertel; Jeremy Luban; Julia Lienard; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

Review 7.  Host hindrance to HIV-1 replication in monocytes and macrophages.

Authors:  Anna Bergamaschi; Gianfranco Pancino
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

Review 8.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

9.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Nguyen; Baek Kim; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-11-13       Impact factor: 3.616

10.  Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.